GAA
CRBU icon

Green Alpha Advisors’s Caribou Biosciences CRBU Stock Holding History

Green Alpha Advisors’s Portfolio CRBU Stock Details CRBU Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$710K Sell
373,650
-1,489
-0.4% -$2.56K 0.7% 37
2025
Q4 		$596K Buy
375,139
+11,440
+3% +$24K 0.55% 60
2025
Q3 		$847K Sell
363,699
-61,980
-15% -$117K 0.82% 40
2025
Q2 		$536K Sell
425,679
-6,646
-2% -$6.54K 0.51% 62
2025
Q1 		$395K Buy
432,325
+251,271
+139% +$327K 0.42% 72
2024
Q4 		$288K Buy
181,054
+77,840
+75% +$157K 0.23% 115
2024
Q3 		$202K Buy
103,214
+25,843
+33% +$52.9K 0.16% 122
2024
Q2 		$127K Sell
77,371
-6,150
-7% -$19.7K 0.1% 130
2024
Q1 		$429K Buy
83,521
+3,957
+5% +$24.4K 0.31% 107
2023
Q4 		$456K Sell
79,564
-30,960
-28% -$153K 0.33% 112
2023
Q3 		$528K Buy
110,524
+4,698
+4% +$29.1K 0.41% 91
2023
Q2 		$450K Buy
105,826
+21,359
+25% +$96K 0.3% 114
2023
Q1 		$449K Buy
84,467
+9,360
+12% +$58.3K 0.31% 111
2022
Q4 		$472K Buy
75,107
+5,731
+8% +$51K 0.39% 102
2022
Q3 		$732K Sell
69,376
-182,896
-72% -$1.7M 0.62% 71
2022
Q2 		$1.37M Buy
252,272
+202,598
+408% +$1.55M 0.31% 64
2022
Q1 		$456K Buy
49,674
+14,082
+40% +$148K 0.31% 110
2021
Q4 		$537K Buy
35,592
+2,756
+8% +$53.6K 0.36% 105
2021
Q3 		$784K Buy
+32,836
New +$803K 0.54% 96

Other funds holding CRBU

P
Pfizer New York $239M AUM 232.47% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
KCM
Kynam Capital Management Princeton, New Jersey $1.62B AUM 138.67% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Aberdeen Group
Aberdeen Group Edinburgh, United Kingdom $71.2B AUM 41.74% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Green Alpha Advisors's CRBU Position: Q1 2026 in Review

Green Alpha Advisors reduced its Caribou Biosciences (CRBU) stake by 0.4% in Q1 2026, selling an estimated $2.56K and leaving 373,650 shares worth $710K. The position accounts for 0.7% of the portfolio, ranked #37.

Green Alpha Advisors first reported a position in CRBU in Q3 2021 and has held it in 19 quarters since. The position peaked at $1.37M in Q2 2022. 137 funds tracked by Wall St. Rank hold CRBU as of Q1 2026.

  • Green Alpha Advisors held 373,650 shares of Caribou Biosciences worth $710K as of Q1 2026.
  • Green Alpha Advisors sold 1,489 Caribou Biosciences shares in Q1 2026, an estimated $2.56K.
  • Caribou Biosciences made up 0.7% of Green Alpha Advisors's portfolio in Q1 2026, its #37 holding.
  • Green Alpha Advisors first reported a position in Caribou Biosciences in Q3 2021 and has held it in 19 quarters since.
  • Green Alpha Advisors's Caribou Biosciences position peaked at $1.37M in Q2 2022.
  • 137 funds tracked by Wall St. Rank held Caribou Biosciences as of Q1 2026.

Based on Green Alpha Advisors's 13F filing for Q1 2026, filed 7 Apr 2026.